In addition to its work on essential childhood vaccines, Gavi manages stockpiles of vaccines against Cholera, Yellow Fever, meningococcal disease and Ebola, giving it a crucial role in outbreak response. Gavi’s goal is to continue that catch-up while also reaching the millions of “zero dose” children still missing out on life-saving vaccinations.Ĭommenting these figures, Prof José Manuel Barroso, Gavi Board Chair, said: "For over twenty years, Gavi’s operating model has been a solution to the world’s immunisation challenges and at no time was this more the case than in recent years, when it has helped countries not only to weather the worst public health crisis in a century, but protect more and more people from deadly, preventable diseases.” This contrasts with a 5% point drop between 20 and will help coverage levels return closer to their historical baseline. Based on a preliminary analysis of country administrative data shared with Gavi, coverage across Gavi-implementing countries increased by approximately three percentage points in 2022. These encouraging signs that resilient health systems in the 57 Gavi-implementing countries are having some success in bouncing back following the pandemic appear to be borne out by preliminary data demonstrating a recovery of routine immunisation coverage in 2022. These new figures were unveiled at the Global Vaccine Impact Conference, co-hosted by the Spanish Government, which kicked off in Madrid today and saw the publication of a new report, Raising Generation ImmUnity.Įvery year, Gavi provides vaccines to countries to protect half the world’s children and despite the huge strain placed on countries’ health systems by the COVID-19 pandemic, the report finds that it remains on or ahead of schedule in eight of 11 key ambitious commitments it made for the period 2021–2025.1 These include efforts to immunise a further 300 million children, prevent between seven and eight million future deaths and unlock US$ 80-US$ 100 billion in economic benefits.Ĭommitments where Gavi's ambitious goals require additional effort during the current five-year period are in securing further cost savings from manufacturers, increasing countries’ own financial contribution and in helping countries transition away from Gavi support. In total, Gavi has enabled roughly 6 billion vaccinations around the world, protecting children and adults against 19 infectious diseases. Geneva/Madrid, 13 June, 2023 – Gavi, the Vaccine Alliance has helped to vaccinate over one billion children with routine vaccines since it was established in 2000 – alongside enabling billions of critical vaccinations during campaigns, emergencies and pandemics – and is on course to achieve a majority of its 2025 strategic objectives. This comes as global leaders gather in Madrid for the Global Vaccine Impact Conference, an opportunity to learn from the COVAX response to COVID-19 and global health threats to continue building a pandemic prevention, preparedness and response infrastructure The Alliance is on track to immunise 300 million children between 20 and prevent 7-8 million deaths during this period, generating an additional US$ 80-100 billion economic benefits Gavi, the Vaccine Alliance, has now facilitated the immunisation of more than one billion children with childhood vaccines Vaccine Alliance reaches more than one billion children
0 Comments
Leave a Reply. |